Workflow
MLOPTIC (688502)
icon
Search documents
茂莱光学(688502) - 2025年半年度权益分派实施公告
2025-09-15 10:15
证券代码:688502 证券简称:茂莱光学 公告编号:2025-071 南京茂莱光学科技股份有限公司 2025年半年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 是否涉及差异化分红送转:是 每股分配比例 每股现金红利0.13元 相关日期 上市公司自律监管指引第 7 号——回购股份》等相关法律、行政法规、部门规章 及其他规范性文件以及《公司章程》的有关规定,公司回购专用证券账户中的股 份不享有股东会表决权、利润分配、公积金转增股本、认购新股等权利。 重要内容提示: | 股权登记日 | 除权(息)日 | 现金红利发放日 | | --- | --- | --- | | 2025/9/19 | 2025/9/22 | 2025/9/22 | 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 4 月 28 日的2024年年度股东会授权,经 2025 年 8 月 28 日第四届董事会第十四次会议审议通过后实施。 二、 分配方案 1. 发放年度:2025年半年度 2. 分派对象: 截至股权登记 ...
茂莱光学(688502) - 国浩律师(南京)事务所关于茂莱光学2025年第二次临时股东会法律意见书
2025-09-12 09:45
国浩律师(南京)事务所 关于南京茂莱光学科技股份有限公司 2025 年第二次临时股东会 中国江苏省南京市汉中门大街 309 号 B 座 5、7、8 层 邮编:210036 5、7、8/F, Block B, 309 Hanzhongmen Street, Nanjing, China, 210036 电话/Tel: +86 25 8966 0900 传真/Fax: +86 25 89660966 网址/Website: http://www.grandall.com.cn 之 法律意见书 国浩律师(南京)事务所 关于南京茂莱光学科技股份有限公司 2025 年第二次临时股东会之 法律意见书 致:南京茂莱光学科技股份有限公司 根据《中华人民共和国证券法》《中华人民共和国公司法》以及中国证券监 督管理委员会《上市公司股东会规则》的规定,本所接受南京茂莱光学科技股份 有限公司(以下简称"公司")的聘请,指派潘希、衡雪律师出席公司 2025 年 第二次临时股东会(以下简称"本次股东会"),并就公司本次股东会出具法律 意见书。 为出具本法律意见书,本所律师参加了公司本次股东会,并对本次股东会召 集和召开的相关事实以及公司 ...
茂莱光学(688502) - 2025年第二次临时股东会决议公告
2025-09-12 09:45
证券代码:688502 证券简称:茂莱光学 公告编号:2025-070 南京茂莱光学科技股份有限公司 2025年第二次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 本次会议是否有被否决议案:无 一、 会议召开和出席情况 (一) 股东会召开的时间:2025 年 9 月 12 日 (二) 股东会召开的地点:江苏省南京市江宁开发区铺岗街 398 号会议室 (三) 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况: | 1、出席会议的股东和代理人人数 | 127 | | --- | --- | | 普通股股东人数 | 127 | | 2、出席会议的股东所持有的表决权数量 | 36,777,251 | | 普通股股东所持有表决权数量 | 36,777,251 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比例(%) | 69.9827 | | 普通股股东所持有表决权数量占公司表决权数量的比例(%) | 69.9827 | (四) 表决方式是否符合 ...
64只科创板股票跻身百元股阵营
Core Insights - The average stock price of the Sci-Tech Innovation Board is 39.91 yuan, with 64 stocks priced over 100 yuan, and the highest priced stock is Cambrian-U at 1387.00 yuan, which increased by 8.96% today [1][2]. Stock Performance - A total of 524 stocks on the Sci-Tech Innovation Board rose today, while 61 stocks fell. The average increase for stocks priced over 100 yuan was 5.04%, with notable gainers including Tengjing Technology, Haiguang Information, and Juguang Technology [1][2]. - Tengjing Technology's stock price reached 101.44 yuan, marking a 20.00% increase, with a turnover rate of 15.04% and a trading volume of 1.812 billion yuan, resulting in a net inflow of 163 million yuan [1]. Premium Analysis - The average premium of stocks priced over 100 yuan relative to their issue price is 393.85%, with Cambrian-U, Anji Technology, and Baili Tianheng showing the highest premiums of 2054.06%, 1313.03%, and 1308.91% respectively [2]. - The concentration of stocks priced over 100 yuan is primarily in the electronics, pharmaceutical, and computer sectors, with 29, 12, and 9 stocks respectively [2]. Capital Flow - The net inflow of capital into stocks priced over 100 yuan today totaled 3.84 billion yuan, with significant inflows into Haiguang Information, Dingtong Technology, and Wealth Trend [2]. - The total margin financing balance for stocks priced over 100 yuan is 75.452 billion yuan, with the highest balances held by SMIC, Cambrian-U, and Haiguang Information [2].
科创板平均股价38.24元,60股股价超百元
Group 1 - The average stock price of the Sci-Tech Innovation Board is 38.24 yuan, with 60 stocks priced over 100 yuan, and the highest priced stock is Cambrian-U at 1273.00 yuan, which increased by 3.66% [1][2] - Among the stocks priced over 100 yuan, 33 stocks increased in price today, with notable gainers including DingTong Technology, JiePuTe, and XinQi Micro [1][2] - The average premium of the stocks priced over 100 yuan relative to their issue price is 379.18%, with Cambrian-U, BaiLi TianHeng, and AnJi Technology showing the highest premiums of 1877.02%, 1288.70%, and 1238.73% respectively [1][2] Group 2 - The sectors with the highest concentration of stocks priced over 100 yuan on the Sci-Tech Innovation Board include electronics (26 stocks), pharmaceuticals (12 stocks), and computers (9 stocks) [2] - The net inflow of main funds into stocks priced over 100 yuan today totaled 765 million yuan, with the highest net inflows seen in HaiGuang Information, LanQi Technology, and Cambrian-U [2] - The total margin balance for stocks priced over 100 yuan is 72.93 billion yuan, with the highest balances in ZhongXin International, Cambrian-U, and HaiGuang Information [2][3]
茂莱光学股价跌5.01%,安联基金旗下1只基金重仓,持有1.53万股浮亏损失34.74万元
Xin Lang Cai Jing· 2025-09-10 03:01
Group 1 - The core point of the news is that Maolai Optical experienced a decline of 5.01% in its stock price, reaching 430.31 CNY per share, with a trading volume of 404 million CNY and a turnover rate of 5.45%, resulting in a total market capitalization of 22.72 billion CNY [1] - Maolai Optical, established on August 24, 1999, and listed on March 9, 2023, is located in Jiangning Development Zone, Nanjing, Jiangsu Province. The company specializes in the research, design, manufacturing, and sales of precision optical devices, high-end optical lenses, and advanced optical systems [1] - The revenue composition of Maolai Optical includes optical devices at 44.03%, optical lenses at 28.34%, optical systems at 27.00%, services at 0.61%, and others at 0.03% [1] Group 2 - Allianz Fund holds a significant position in Maolai Optical, with its Allianz China Select Mixed A Fund (021981) owning 15,300 shares, accounting for 3.48% of the fund's net value, making it the largest holding [2] - The estimated floating loss for the Allianz China Select Mixed A Fund today is approximately 347,400 CNY [2] - The Allianz China Select Mixed A Fund was established on September 3, 2024, with a current size of 1.03 billion CNY and has achieved a year-to-date return of 46.59%, ranking 986 out of 8,184 in its category [2]
A股上市宁企“半年报”全部发布
Nan Jing Ri Bao· 2025-09-05 03:27
Core Viewpoint - The financial performance of A-share listed companies in Nanjing for the first half of the year shows strong growth, particularly in the banking and securities sectors, driven by their focus on serving the real economy and innovation in technology [1][2][3]. Financial Performance - Nanjing's A-share listed companies have a total market capitalization of approximately 1.81 trillion yuan, with Jiangsu Bank, Nanjing Bank, and Huatai Securities leading in net profits of 20.24 billion yuan, 12.62 billion yuan, and 7.55 billion yuan respectively [1][2]. - Jiangsu Bank reported a revenue of 44.86 billion yuan, an increase of 7.78% year-on-year, and a net profit growth of 8.05% [2]. - Nanjing Bank achieved a revenue of 28.48 billion yuan, with a year-on-year growth of 8.64%, and a net profit increase of 8.84% [2]. - Huatai Securities saw a revenue of 16.22 billion yuan, with a significant year-on-year increase of 31.01%, and a net profit growth of 42.16% [2]. Service to Real Economy - Jiangsu Bank's focus on supporting manufacturing and infrastructure projects led to a manufacturing loan balance of 360.6 billion yuan, growing by 18.90% year-on-year, and infrastructure loans reaching 691.2 billion yuan, up by 31% [3]. - Nanjing Bank emphasized service to key industries, with green finance, inclusive small and micro finance, and technology finance loans growing by 27.79%, 12.51%, and 12.42% respectively [3]. - Huatai Securities maintained a strong development trend by innovating its business and service models [3]. Innovation and Technology - Nanjing Steel's half-year report highlighted a net profit of 1.46 billion yuan, with advanced steel material sales contributing significantly to profits [4][5]. - Nanjing Steel's innovation strategy included breakthroughs in advanced steel materials and participation in national key research projects [5]. - Guodian NARI's report showcased its technological advancements, achieving a revenue of 24.24 billion yuan, up by 19.54% year-on-year, and a net profit of 2.95 billion yuan, growing by 8.82% [6]. Globalization Strategy - Companies like Maolai Optical and Nanwei Medical are leveraging globalization for growth, with Maolai Optical reporting a revenue of 319 million yuan, up by 32.26%, and a net profit increase of 110.36% [7][8]. - Nanwei Medical achieved a revenue of 1.565 billion yuan, with overseas revenue accounting for 58% of total income, reflecting its global expansion efforts [9].
科创板平均股价37.44元,7股股价超300元
Group 1 - The average stock price of the Sci-Tech Innovation Board is 37.44 yuan, with 57 stocks priced over 100 yuan, and the highest priced stock is Cambrian-U at 1202.00 yuan, which fell by 14.45% today [1] - Among the stocks priced over 100 yuan, 80 stocks increased in price while 504 stocks decreased, with an average decline of 5.35% for the hundred-yuan stocks today [1] - The average premium of the hundred-yuan stocks relative to their issue price is 373.57%, with Cambrian-U, Baile Tianheng, and Anji Technology having the highest premiums of 1766.75%, 1489.07%, and 1211.41% respectively [1] Group 2 - The net outflow of main funds from the hundred-yuan stocks today totaled 4.734 billion yuan, with Cambrian-U, Naxinwei, and Haooubo seeing the highest net inflows of 141.35 million yuan, 60.21 million yuan, and 50.51 million yuan respectively [2] - The total margin balance for hundred-yuan stocks is 69.882 billion yuan, with the highest margin balances held by SMIC, Cambrian-U, and Haiguang Information at 11.623 billion yuan, 11.311 billion yuan, and 7.619 billion yuan respectively [2]
茂莱光学9月3日获融资买入4562.61万元,融资余额3.14亿元
Xin Lang Zheng Quan· 2025-09-04 01:25
Core Viewpoint - The financial performance and trading activity of Maolai Optical have shown significant growth, with a notable increase in revenue and net profit, alongside high levels of financing and margin trading activity [1][2]. Financial Performance - For the first half of 2025, Maolai Optical achieved a revenue of 319 million yuan, representing a year-on-year growth of 32.26% [2]. - The net profit attributable to shareholders reached 32.76 million yuan, marking a substantial increase of 110.36% compared to the previous period [2]. Trading Activity - On September 3, Maolai Optical's stock price increased by 0.72%, with a trading volume of 515 million yuan [1]. - The financing buy-in amount for the same day was 45.63 million yuan, while the financing repayment was 55.82 million yuan, resulting in a net financing outflow of 10.20 million yuan [1]. - As of September 3, the total margin trading balance for Maolai Optical was 316 million yuan, with the financing balance accounting for 4.43% of the circulating market value [1]. Shareholder Information - As of June 30, 2025, the number of shareholders for Maolai Optical was 6,945, an increase of 13.63% from the previous period [2]. - The average number of circulating shares per shareholder was 2,419, which decreased by 11.99% [2]. Dividend Distribution - Since its A-share listing, Maolai Optical has distributed a total of 82.32 million yuan in dividends [3]. Institutional Holdings - As of June 30, 2025, the largest circulating shareholder was Nuoan Growth Mixed A, holding 1.10 million shares, unchanged from the previous period [4]. - The second-largest shareholder, Yongying Semiconductor Industry Selected Mixed A, increased its holdings by 360,000 shares to 720,000 shares [4]. - New institutional shareholders include Financial通资管 Digital Economy Mixed Initiated A, holding 387,900 shares [4].
茂莱光学2025年中报简析:营收净利润同比双双增长,盈利能力上升
Zheng Quan Zhi Xing· 2025-08-30 23:26
Core Viewpoint - Maolai Optical (688502) reported strong financial performance for the first half of 2025, with significant increases in revenue and net profit compared to the previous year, indicating improved profitability and operational efficiency [1]. Financial Performance - Total revenue for the first half of 2025 reached 319 million yuan, a year-on-year increase of 32.26% [1]. - Net profit attributable to shareholders was 32.76 million yuan, up 110.36% year-on-year [1]. - In Q2 2025, total revenue was 177 million yuan, reflecting a 35.7% increase year-on-year, while net profit for the quarter was 16.11 million yuan, up 42.72% [1]. - Gross margin improved to 49.65%, an increase of 4.16% year-on-year, and net margin rose to 10.27%, up 59.05% [1]. - Total operating expenses were 66.62 million yuan, accounting for 20.89% of revenue, a decrease of 14.47% year-on-year [1]. Key Financial Ratios - Earnings per share (EPS) increased to 0.62 yuan, a rise of 111.36% year-on-year [1]. - Operating cash flow per share was 0.14 yuan, up 116.46% year-on-year [1]. - The company's net asset value per share was 22.72 yuan, an increase of 4.38% year-on-year [1]. Business Evaluation - The company's return on invested capital (ROIC) was 2.88% last year, indicating a relatively weak capital return [3]. - Historical data shows a median ROIC of 14.97% since the company went public, suggesting potential for better investment returns [3]. - The company's performance is primarily driven by R&D and capital expenditures, necessitating careful monitoring of capital spending projects [3]. Fund Holdings - The largest fund holding Maolai Optical is the Yongying Semiconductor Industry Mixed Fund A, with 720,000 shares and a recent net value of 1.5345, reflecting a 136.66% increase over the past year [4]. - Other funds have varied positions, with some increasing their holdings while others have reduced them [4]. R&D and Profitability - The company indicated that gross margins during the R&D phase are typically lower than during mass production, with margins influenced by customer demand and product structure [5]. - As R&D orders transition to mass production, the company's overall gross margin is expected to recover [5].